Our Team
Our Team
Who we are
We are a team of highly motivated individuals with strong investment track records and a deep understanding of science and technology that works side by side with entrepreneurs who wish to improve healthspan and lifespan. We bring multiple decades of experience creating, launching, and building early-stage companies to the field of regenerative medicine.
Our team’s long-standing work with leading academic labs and research institutions in the regenerative medicine field gives us early access to the “Cambrian” explosion of novel technologies being developed in the field. Breakthroughs in regenerative medicine will be critical to targeting the drivers of disease in conditions spanning neurodegeneration, cardiovascular disease, cancer, and autoimmune diseases, as well as processes that span disease categories such as fibrosis and aging.
Our team, partners, affiliates, and advisors are individually successful as investors, scientists, and entrepreneurs.
Partnership
with
Panacea Venture
Eos has a close working relationship with Panacea Venture, a global life sciences focused venture capital firm backed by prominent investors, family offices, and institutions. Panacea’s founder has over two decades of biotech/healthcare investing experience at top venture capital firms and serves as the Chair of Eos’ Board of Directors. Panacea has been instrumental in the founding of Eos and is fully committed to supporting Eos’ vision. Eos has leveraged and will continue to leverage the Panacea team and its collective experience, knowledge base, and skill sets. Panacea has established a strong and consistent track record of success, and we will continue to access its extensive networks and resources to benefit Eos’ own portfolio of investments.
THE EOS OPPORTUNITY
Compelling Investment Thesis Based on Convergence of Niche, Timing, and Team
Eos BioInnovation is leveraging current advancements and breakthroughs in cell, gene, and tissue therapies across the regenerative medicine value chain that will fundamentally alter healthcare. In lieu of daily “maintenance medicines,” regenerative medicine aims to cure the root causes of disease and provide treatments for the most challenging diseases and conditions across a variety of treatment modalities. An investment in Eos is an investment in the promise of curative therapies and cutting-edge technologies developed, vetted, and built by world leading experts.
Eos BioInnovation is investing in curative
therapies and technologies
Copyright © Eos 2022 - All Rights Reserved
Copyright © Eos 2022 - All Rights Reserved
Eos BioInnovation is investing in curative
therapies and technologies